ATF Group (PDF) Limited
ATF Group (PDF) Limited (ATF) was established in 2005 as a pro-active investment company.
Amongst its 479 shareholders is a unique multi-state
alliance of publicly funded Research Institutions and
Universities.
Evivar Medical Pty Ltd
ATF's principal investment is Evivar MedicalPty Ltd. At present, ATF owns 45% of Evivar.
Evivar provides a secure, on-line decision support tool for clinicians treating patients with Hepatitis B Virus (HBV). Evivar enables physicians to individualise the treatment of patients with chronic HBV, selecting the right drug, at the right time in response to the viral mutations identified.